{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "PF-04965842",
        "type": {
          "id": "e59babf5-ea76-41ec-94af-25c471ede611",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "8a20a22c-7e74-4edd-be09-b4297363f4cb",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "An orally bioavailable small molecule that selectively inhibits JAK1 by blocking the ATP binding site.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Placebo",
        "type": {
          "id": "605a9d70-b645-4470-b958-38cfb0a37d9f",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "role": {
          "id": "dc09a89c-297d-48e2-ae9d-57fdc401c9e6",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Matching placebo used in the double-blind maintenance treatment period.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Topical therapy",
        "type": {
          "id": "6b60dd76-abf5-4a5b-bdbb-626d9a3ac835",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "b7c26bcb-5d89-402e-8945-4f477b31e345",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Topical therapy per local standard of care (SOC) used in combination with PF-04965842 during the rescue period.",
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Emollients",
        "type": {
          "id": "0f1d105c-1faf-47e4-ac93-c7abd5066fc6",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "870fdc11-8130-4dbd-9b6a-c7a4c5bf844a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Non-medicated topical therapies.",
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Acetylsalicylic acid",
        "type": {
          "id": "96bd55e9-b37a-4998-9f7b-d26dabcd6dbe",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "8af97806-3c9f-43b9-8496-f01463e8af0a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Low dose (≤100 mg QD) permitted for cardiovascular prophylaxis."
      },
      {
        "id": "int_6",
        "name": "Topical corticosteroids (TCS)",
        "type": {
          "id": "0589ae7b-901c-4e1a-926e-b047d9c4214e",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "45caab53-0734-4001-9786-3d8c00b2e22c",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Must be washed out during the screening period."
      },
      {
        "id": "int_7",
        "name": "Topical calcineurin inhibitors (TCI)",
        "type": {
          "id": "965f4e7f-b8db-4153-ab41-e0a3d9f6b698",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "5d451844-80a1-4cc3-8901-ba270cc7115c",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Must be washed out during the screening period."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "PF-04965842 tablets",
        "administrableDoseForm": {
          "id": "82e48c99-f37b-4217-9e60-037de0fb8635",
          "code": "C42998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Tablet",
          "standardCode": {
            "id": "83b06842-2367-4897-9971-41a4f3ac059c",
            "code": "C42998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Tablet",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "d1bdeb36-b07a-4d54-b214-ba32e03ff684",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "100 mg",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Pfizer"
      },
      {
        "id": "prod_2",
        "name": "PF-04965842 tablets",
        "administrableDoseForm": {
          "id": "3107d487-4019-4fab-99fa-df214af5a2a1",
          "code": "C42998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Tablet",
          "standardCode": {
            "id": "8acaa384-4372-4d31-b527-f0ac21cb2f3d",
            "code": "C42998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Tablet",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "4f5ffa6b-b89b-4df2-93b5-9b76e259af92",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "200 mg",
        "manufacturer": "Pfizer"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Open-label Run-in Induction",
        "instanceType": "Administration",
        "dose": "200 mg",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "12 weeks"
      },
      {
        "id": "admin_2",
        "name": "Double-blind Maintenance (High Dose)",
        "instanceType": "Administration",
        "dose": "200 mg",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "40 weeks"
      },
      {
        "id": "admin_3",
        "name": "Double-blind Maintenance (Low Dose)",
        "instanceType": "Administration",
        "dose": "100 mg",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "40 weeks"
      },
      {
        "id": "admin_4",
        "name": "Open-label Rescue Treatment",
        "instanceType": "Administration",
        "dose": "200 mg",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "12 weeks"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "PF-04965842",
        "instanceType": "Substance",
        "description": "Selective Janus kinase 1 (JAK1) inhibitor"
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "ePRO device",
        "instanceType": "MedicalDevice",
        "manufacturer": "Not specified"
      }
    ],
    "summary": {
      "interventionCount": 7,
      "productCount": 2,
      "deviceCount": 1
    }
  },
  "rawResponse": [
    {
      "interventions": [
        {
          "name": "PF-04965842",
          "role": "Investigational Product",
          "description": "An orally bioavailable small molecule that selectively inhibits JAK1 by blocking the ATP binding site."
        },
        {
          "name": "Placebo",
          "role": "Placebo",
          "description": "Matching placebo used in the double-blind maintenance treatment period."
        },
        {
          "name": "Topical therapy",
          "role": "Rescue Medication",
          "description": "Topical therapy per local standard of care (SOC) used in combination with PF-04965842 during the rescue period."
        },
        {
          "name": "Emollients",
          "role": "Concomitant Medication",
          "description": "Non-medicated topical therapies."
        },
        {
          "name": "Acetylsalicylic acid",
          "role": "Concomitant Medication",
          "description": "Low dose (≤100 mg QD) permitted for cardiovascular prophylaxis."
        },
        {
          "name": "Topical corticosteroids (TCS)",
          "role": "Prior Medication",
          "description": "Must be washed out during the screening period."
        },
        {
          "name": "Topical calcineurin inhibitors (TCI)",
          "role": "Prior Medication",
          "description": "Must be washed out during the screening period."
        }
      ],
      "products": [
        {
          "name": "PF-04965842 tablets",
          "doseForm": "Tablet",
          "strength": "100 mg",
          "manufacturer": "Pfizer"
        },
        {
          "name": "PF-04965842 tablets",
          "doseForm": "Tablet",
          "strength": "200 mg",
          "manufacturer": "Pfizer"
        }
      ],
      "substances": [
        {
          "name": "PF-04965842",
          "description": "Selective Janus kinase 1 (JAK1) inhibitor"
        }
      ],
      "administrations": [
        {
          "name": "Open-label Run-in Induction",
          "dose": "200 mg",
          "frequency": "once daily",
          "route": "Oral",
          "duration": "12 weeks"
        },
        {
          "name": "Double-blind Maintenance (High Dose)",
          "dose": "200 mg",
          "frequency": "once daily",
          "route": "Oral",
          "duration": "40 weeks"
        },
        {
          "name": "Double-blind Maintenance (Low Dose)",
          "dose": "100 mg",
          "frequency": "once daily",
          "route": "Oral",
          "duration": "40 weeks"
        },
        {
          "name": "Open-label Rescue Treatment",
          "dose": "200 mg",
          "frequency": "once daily",
          "route": "Oral",
          "duration": "12 weeks"
        }
      ],
      "devices": [
        {
          "name": "ePRO device",
          "manufacturer": "Not specified",
          "purpose": "Electronic tablet used for daily collection of Pruritus NRS and PSAAD data."
        }
      ]
    }
  ]
}